NCT02363270

Brief Summary

Our previous published research comparing the efficacy of intravenous ketamine to morphine has shown ketamine to provide equivalent relief of moderate to severe acute pain in emergency medicine patients. Secondary analysis of the previous published research has also revealed ketamine to have statistically more side effects. The investigators believe that increasing the time of administration of the ketamine, from a push injection to a drip infusion, will minimize the side effects experienced by recipients of ketamine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Apr 2015

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 13, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2016

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2017

Completed
7 months until next milestone

Results Posted

Study results publicly available

October 2, 2017

Completed
Last Updated

November 22, 2017

Status Verified

October 1, 2017

Enrollment Period

1.4 years

First QC Date

February 9, 2015

Results QC Date

March 18, 2017

Last Update Submit

October 19, 2017

Conditions

Keywords

Analgesiaketamine

Outcome Measures

Primary Outcomes (1)

  • Overall Rate of Feeling Unreality

    Overall rate of feeling of unreality as measured by Side Effects Rating Scale for Dissociative Anesthetics (SERSDA)

    30 minutes

Study Arms (2)

IV Push Group

ACTIVE COMPARATOR

Ketamine medication given via IV Push. IV Push is the intervention.

Procedure: Ketamine

IV Drip Group

ACTIVE COMPARATOR

Ketamine medication given via IV Drip. IV Drip is the intervention.

Procedure: Ketamine

Interventions

KetaminePROCEDURE

IV Push or or IV Drip

IV Drip GroupIV Push Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Emergency Medicine patients
  • Adult patients (18-65 years of age)
  • Moderate to severe pain (Numeric Pain Rating Score =5).
  • Patients must be awake, alert and oriented to time, place and person.
  • Patients must be able to demonstrate understanding of the informed consent, and also able to verbalize how much pain they are having on the 10 point Numeric Rating Pain Scale, and the nature of the side effects they may be experiencing from the IV analgesia

You may not qualify if:

  • Patients with cognitive deficits that are not able to demonstrate understanding as described above.
  • Patient's reported weight of less than 45kg or more than 115kg.
  • Patients with altered mental status, alcohol intoxication, eye trauma.
  • Patients with hemodynamic instability (Systolic Blood pressure \<90), and malignant hypertension.
  • allergy to ketamine
  • Pregnancy or breast feeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maimonides Medical Center

Brooklyn, New York, 11219, United States

Location

Related Publications (7)

  • 1. Abdullah M. Ketamine. A new look at an old drug. M ABDULLAH. anaesthetics.ukzn.ac.za/.../Ketamine_a_new_look_at_an_old_drug_...(accessed on 12/21/11)

    BACKGROUND
  • Javery KB, Ussery TW, Steger HG, Colclough GW. Comparison of morphine and morphine with ketamine for postoperative analgesia. Can J Anaesth. 1996 Mar;43(3):212-5. doi: 10.1007/BF03011736.

    PMID: 8829857BACKGROUND
  • Lester L, Braude DA, Niles C, Crandall CS. Low-dose ketamine for analgesia in the ED: a retrospective case series. Am J Emerg Med. 2010 Sep;28(7):820-7. doi: 10.1016/j.ajem.2009.07.023. Epub 2010 Apr 2.

    PMID: 20837262BACKGROUND
  • Richards JR, Rockford RE. Low-dose ketamine analgesia: patient and physician experience in the ED. Am J Emerg Med. 2013 Feb;31(2):390-4. doi: 10.1016/j.ajem.2012.07.027. Epub 2012 Oct 4.

    PMID: 23041484BACKGROUND
  • Gurnani A, Sharma PK, Rautela RS, Bhattacharya A. Analgesia for acute musculoskeletal trauma: low-dose subcutaneous infusion of ketamine. Anaesth Intensive Care. 1996 Feb;24(1):32-6. doi: 10.1177/0310057X9602400106.

    PMID: 8669651BACKGROUND
  • Galinski M, Dolveck F, Combes X, Limoges V, Smail N, Pommier V, Templier F, Catineau J, Lapostolle F, Adnet F. Management of severe acute pain in emergency settings: ketamine reduces morphine consumption. Am J Emerg Med. 2007 May;25(4):385-90. doi: 10.1016/j.ajem.2006.11.016.

    PMID: 17499654BACKGROUND
  • Ahern TL, Herring AA, Miller S, Frazee BW. Low-Dose Ketamine Infusion for Emergency Department Patients with Severe Pain. Pain Med. 2015 Jul;16(7):1402-9. doi: 10.1111/pme.12705. Epub 2015 Feb 3.

    PMID: 25643741BACKGROUND

MeSH Terms

Conditions

PainAgnosia

Interventions

Ketamine

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Results Point of Contact

Title
Dr. Sergey Motov
Organization
Maimonides Medical Center

Study Officials

  • Sergey Motov, MD

    Maimonides Medical Center

    PRINCIPAL INVESTIGATOR
  • John Marshall, MD

    Maimonides Medical Center

    STUDY CHAIR
  • Christian Fromm, MD

    Maimonides Medical Center

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Manager

Study Record Dates

First Submitted

February 9, 2015

First Posted

February 13, 2015

Study Start

April 1, 2015

Primary Completion

August 15, 2016

Study Completion

February 28, 2017

Last Updated

November 22, 2017

Results First Posted

October 2, 2017

Record last verified: 2017-10

Locations